Navigation Links
AccessClosure, Inc. Marches to the Millionth Mynx!
Date:9/27/2011

MOUNTAIN VIEW, Calif., Sept. 27, 2011 /PRNewswire/ -- AccessClosure, Inc., a leading manufacturer of extravascular closure devices, announced today the shipment of its one millionth Mynx unit. The Mynx Vascular Closure Device received its FDA approval in May 2007, following with its full commercial launch in September 2007. Physician feedback attributes the achievement of this monumental milestone to the fact that the Mynx sealant is extravascular, bio-inert and non-thrombogenic, while leaving nothing behind intra-arterially.

(Logo: http://photos.prnewswire.com/prnh/20110111/SF27857LOGO)

"It is gratifying that one million patients will have benefited from the Mynx device just four and a half years after introduction to the marketplace. Excellent clinical efficacy and safety have been demonstrated with the Mynx device, and both physicians and their patients greatly appreciate the device's comfort profile," said Gregory D. Casciaro, President and CEO of AccessClosure, Inc.

In addition, increased patient comfort continues to resonate with both physicians and nurses as one of their top selection criteria in choosing the Mynx as their preferred extravascular closure device. Results from a recent prospective, randomized study indicate a significant reduction in pain with the Mynx Vascular Closure Device when compared to competitive devices. The study found that 88% of patients find closure to be the most painful part of the procedure when a competitive device was used compared to 34% of patients when the Mynx device was used.  

"Today is a monumental occasion for AccessClosure, Inc.," said Fred Khosravi, Chairman of the Board and co-founder of AccessClosure. "Vascular closure has been one of the most competitive segments in the medical device marketplace, controlled by a handful of competitors.  Not since the Mynx received its approval four years ago has any other company been so well accepted and utilized in this space. The success of Mynx is just the beginning. AccessClosure, Inc. will continue to meet the needs of its customer base for years to come with its robust product pipeline."

Also contributing to the overall success of Mynx is the continued expansion of its distribution network through international markets; demonstrated most recently with the announcement of the Biosensors International distribution agreement throughout the United Kingdom, Switzerland and France. The Mynx Device is now available through a wide global network of distributors, complementing its direct sales presence in the United States.

About AccessClosure, Inc.

Founded in 2002, AccessClosure, Inc. is a privately held medical device company pioneering innovative access site management products designed to provide a reliable, patient-friendly vascular closure experience. For more information, please visit our website at http://www.accessclosure.com/


'/>"/>
SOURCE AccessClosure, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Systech and Marchesini Showcase Complete Serialization Line at Pack Expo 2010
2. Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices
3. The SCOOTER Store Marks Half-Millionth Life Changed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Columbia, March 27, 2017  Sophiris Bio Inc. ... "Sophiris"), a clinical late-stage biopharmaceutical company developing topsalysin ... diseases, today reported fourth quarter and full year ... Key Corporate Highlights: ... Prostate Cancer. During 2016, the Company reported successful ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... 2017  iCAD (Nasdaq: ICAD), an industry-leading provider ... therapy for the early identification and treatment of ... Premarket Approval (PMA) from the U.S. Food and ... first-of-its-kind, concurrent-read computer aided detection solution for digital ... available on the PowerLook® Breast Health Solutions platform.  ...
Breaking Medicine Technology:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... organization behind the New England Journal of Medicine and NEJM Journal Watch, announces ... Pediatrics Board Review was created by a panel of pediatricians from leading medical ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still in ... of the best days I’ve had in a long time,” she said. , She thinks ... lot of money that I never thought I would have to help my students.” , ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending ... the pending litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil ... am thrilled to announce that we have now reached a settlement agreement regarding ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
Breaking Medicine News(10 mins):